Topic

Signifor / Signifor LAR (pasireotide)

A collection of 29 issues

How to Get Signifor LAR (Pasireotide) Covered by Humana in Georgia: Prior Authorization Requirements and Appeals Guide

Answer Box: Getting Signifor LAR Covered by Humana in Georgia Fastest path to approval: Have your endocrinologist submit prior authorization with documented failure/intolerance of first-generation somatostatin analogs (octreotide/lanreotide) and current IGF-1 or UFC levels. First step today: Call Humana at 1-800-448-6262 to confirm your plan's formulary

Renewing Signifor / Signifor LAR (Pasireotide) Approval with Cigna in Virginia: 2025 Requirements, Timeline & Evidence Guide

Answer Box: Renewing Your Signifor LAR Coverage Cigna typically approves Signifor LAR renewals for 12 months when you demonstrate ongoing clinical response. For Cushing's disease, you'll need recent UFC (urinary free cortisol) showing reduction from baseline. For acromegaly, provide age-adjusted IGF-1 normalization or GH <1.

How to Get Signifor LAR (Pasireotide) Covered by Blue Cross Blue Shield in Georgia: Timeline, Forms & Appeals Guide

Answer Box: Getting Signifor LAR Covered by BCBS Georgia Blue Cross Blue Shield Georgia typically processes Signifor LAR (pasireotide) prior authorization requests within 1-14 days, depending on complexity. For Cushing's disease or acromegaly patients, the fastest path involves: (1) gathering complete lab results (UFC, IGF-1) and prior treatment

How to Get Signifor LAR (Pasireotide) Covered by Humana in Virginia: Appeals, Forms, and Cost-Saving Strategies

Quick Answer: Getting Signifor LAR Covered by Humana in Virginia Signifor LAR requires prior authorization from Humana and is placed in Tier 5 (specialty tier). Your fastest path to approval: 1) Have your endocrinologist submit a prior authorization with complete biochemical evidence (elevated UFC for Cushing's or IGF-1

How to Get Signifor / Signifor LAR (Pasireotide) Covered by UnitedHealthcare in California: Complete Prior Authorization Guide

Answer Box: Getting Signifor Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Signifor (pasireotide) with board-certified endocrinologist involvement and specific biochemical documentation. For Cushing's disease, no step therapy is required—just proof of endogenous hypercortisolism and surgical ineligibility/failure. Submit requests through the UHC Provider Portal

How to Get Signifor/Signifor LAR Covered by UnitedHealthcare in Illinois: Complete Guide to Prior Authorization, Appeals & Forms

Quick Answer: Getting Signifor/Signifor LAR Covered by UnitedHealthcare in Illinois UnitedHealthcare requires prior authorization for Signifor (pasireotide) in Illinois. For Cushing's disease: coverage is approved when pituitary surgery isn't an option or hasn't been curative—no step therapy required. For acromegaly: you must

How Long Does It Take to Get Signifor LAR (Pasireotide) Approved by Humana in New York? Timeline & Appeal Process

Answer Box: Getting Signifor LAR Covered by Humana in New York Timeline: Humana Medicare Advantage must decide on Signifor LAR (pasireotide) prior authorization within 7 calendar days (standard) or 72 hours (expedited) starting January 2026. Currently, most electronic submissions get responses within one business day. Fastest path: Submit complete documentation

How to Get Signifor LAR (Pasireotide) Covered by Cigna in Pennsylvania: Prior Authorization Requirements and Appeals Process

Quick Answer: Getting Cigna Coverage for Signifor LAR in Pennsylvania Cigna requires prior authorization for Signifor/Signifor LAR (pasireotide) with strict medical necessity criteria. Your endocrinologist must document: confirmed acromegaly or Cushing's disease diagnosis, elevated IGF-1/UFC levels, failed surgery or ineligibility, and trial/failure of first-generation somatostatin

How to Get Signifor LAR (Pasireotide) Covered by Aetna in Michigan: Prior Authorization Forms and Appeal Guide

Answer Box: Getting Signifor LAR Covered by Aetna in Michigan Aetna requires prior authorization for Signifor LAR (pasireotide) in Michigan. You must document trial and failure of Somatuline Depot (lanreotide) first, plus provide biochemical evidence (elevated UFC for Cushing's disease or IGF-1 for acromegaly). Submit via CVS Specialty